Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000679893 | SCV000807311 | pathogenic | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | 2017-09-01 | criteria provided, single submitter | clinical testing | This variant has been previously reported as disease-causing and was found once in our laboratory maternally inherited in a 2-year-old female with speech delay, regression, hypoglycemia, abnormal MRI, possible seizures |
Mendelics | RCV002247388 | SCV002519209 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Clinical Genomics Laboratory, |
RCV004555849 | SCV005045037 | uncertain significance | not provided | 2024-04-17 | criteria provided, single submitter | clinical testing | The PRICKLE2 c.1813G>T (p.Val605Phe) variant has been observed in two patients with myoclonic epilepsy, developmental regression and episodes concerning seizures (Tao H et al., PMID: 21276947; Yang Y et al., PMID: 25326635). This variant is only observed on 3/251,414 alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. Computational predictors are uncertain as to the impact of this variant on PRICKLE2 function. This variant has been reported in the ClinVar database as a germline variant of uncertain significance by two submitters and pathogenic by one submitter in an individual with speech delay, regression, hypoglycemia, abnormal brain MRI, and possible seizures. Due to limited information, the clinical significance of this variant is uncertain. |
OMIM | RCV000023710 | SCV000045001 | uncertain significance | Progressive myoclonic epilepsy type 5 | 2011-02-11 | no assertion criteria provided | literature only |